Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Details Narrative)

v3.25.2
Stockholders’ Equity (Details Narrative) - USD ($)
 6 Months Ended
Dec. 24, 2024
Jun. 13, 2024
Jun. 12, 2024
Jun. 22, 2022
Jun. 30, 2025
Jun. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares granted         893,181  
Number of additional granted shares issued         120  
Aggregate vested shares value         $ 2,009,657  
Number of unvested shares         15,181  
Unrecognized value of shares         $ 34,157  
Aggregate intrinsic value of outstanding warrants         $ 37,978  
Closing share price         $ 9.07  
Proceeds from sale of shares         $ 2,499,998
Private Placement [Member] | Chief Executive Officer and Director [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares sold   174,825        
Shares sold price per share   $ 14.30        
Proceeds from sale of shares     $ 2,499,998      
2019 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares granted       1,498,128    
Exercise price       $ 7.63    
Stock granted       $ 9,512,356    
Risk-free interest rate       3.20%    
Voltality rate       106.00%    
Compensation expense         7,193,716 $ 4,815,628
Fair value         $ 2,318,640  
Vesting term         4 years  
Two Thousand Twenty Four Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares granted 1,627,937          
Exercise price $ 12.16          
Stock granted $ 16,190,565          
Risk-free interest rate 4.50%          
Voltality rate 103.00%          
Compensation expense         $ 6,774,623  
Fair value         $ 9,415,942  
Vesting term         3 years  
ATM Agreement [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares sold         320,210 44,697
Shares sold price per share         $ 9.95 $ 14.07
Gross proceeds from sale of shares         $ 3,185,661 $ 628,732
Net proceeds from sale of shares         3,100,668 565,858
Underwriting discounts, commissions and offering expenses         $ 84,993 $ 62,874
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares granted         908,362  
Common stock grant vested shares         0 0